ATE30238T1 - N-acylderivate von peptiden, ihre herstellung und verwendung bei der bekaempfung von krankheiten und mittel dafuer. - Google Patents

N-acylderivate von peptiden, ihre herstellung und verwendung bei der bekaempfung von krankheiten und mittel dafuer.

Info

Publication number
ATE30238T1
ATE30238T1 AT83106587T AT83106587T ATE30238T1 AT E30238 T1 ATE30238 T1 AT E30238T1 AT 83106587 T AT83106587 T AT 83106587T AT 83106587 T AT83106587 T AT 83106587T AT E30238 T1 ATE30238 T1 AT E30238T1
Authority
AT
Austria
Prior art keywords
peptides
acyl derivatives
production
combating diseases
combating
Prior art date
Application number
AT83106587T
Other languages
German (de)
English (en)
Inventor
Hans Peter Dr Albrecht
Horst Dr Kreiskott
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Application granted granted Critical
Publication of ATE30238T1 publication Critical patent/ATE30238T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0823—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Indole Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT83106587T 1982-07-14 1983-07-06 N-acylderivate von peptiden, ihre herstellung und verwendung bei der bekaempfung von krankheiten und mittel dafuer. ATE30238T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19823226241 DE3226241A1 (de) 1982-07-14 1982-07-14 N-acylderivate von peptiden, ihre herstellung und verwendung bei der bekaempfung von krankheiten und mittel dafuer
EP83106587A EP0099057B1 (de) 1982-07-14 1983-07-06 N-Acylderivate von Peptiden, ihre Herstellung und Verwendung bei der Bekämpfung von Krankheiten und Mittel dafür

Publications (1)

Publication Number Publication Date
ATE30238T1 true ATE30238T1 (de) 1987-10-15

Family

ID=6168357

Family Applications (1)

Application Number Title Priority Date Filing Date
AT83106587T ATE30238T1 (de) 1982-07-14 1983-07-06 N-acylderivate von peptiden, ihre herstellung und verwendung bei der bekaempfung von krankheiten und mittel dafuer.

Country Status (6)

Country Link
US (1) US4610817A (member.php)
EP (1) EP0099057B1 (member.php)
JP (1) JPS5931746A (member.php)
AT (1) ATE30238T1 (member.php)
CA (1) CA1257748A (member.php)
DE (2) DE3226241A1 (member.php)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9113219D0 (en) * 1991-06-19 1991-08-07 Fujisawa Pharmaceutical Co Peptide compound,processes for preparation thereof and pharmaceutical composition comprising the same
US6767897B2 (en) * 1994-05-04 2004-07-27 Innapharma, Inc. Therapeutic uses of tri-, tetra-, penta-, and polypeptides
US5767083A (en) * 1994-05-04 1998-06-16 Innapharma, Inc. Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent
US5589460A (en) * 1994-05-04 1996-12-31 Innapharma, Inc. Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1085916A (en) * 1964-12-01 1967-10-04 Nat Res Dev O-acyl hydroxylamines
US3795738A (en) * 1972-12-26 1974-03-05 Abbott Lab Use of l-propyl l-leucyl glycine amide to treat parkinson's disease
US4018912A (en) * 1975-07-28 1977-04-19 Ayerst Mckenna And Harrison Ltd. Tripeptide derivatives with central nervous system activity and preparation thereof
US4041023A (en) * 1976-04-14 1977-08-09 Hoffmann-La Roche Inc. Labelled peptides
GB1592552A (en) * 1976-12-10 1981-07-08 Inst Nat Sante Rech Med Pseudopeptides used as medicaments
WO1980000216A1 (en) * 1978-07-10 1980-02-21 Univ Illinois Inhibition by peptides of tolerance to and dependence on morphine
DE2933713A1 (de) * 1979-08-21 1981-03-12 Bergwerksverband Gmbh, 4300 Essen Verfahren zur reduktion von so (pfeil abwaerts)2 -reichgasen zu elementarem schwefel
US4278595A (en) * 1979-12-10 1981-07-14 Vega Laboratories, Inc. Orally active MIF analogs with an effect on the central nervous system
US4395401A (en) * 1981-09-09 1983-07-26 Smithkline Beckman Corporation Renally active dipeptides

Also Published As

Publication number Publication date
JPS5931746A (ja) 1984-02-20
DE3226241A1 (de) 1984-01-26
DE3374066D1 (en) 1987-11-19
EP0099057A3 (en) 1984-09-12
EP0099057A2 (de) 1984-01-25
JPH0441156B2 (member.php) 1992-07-07
EP0099057B1 (de) 1987-10-14
US4610817A (en) 1986-09-09
CA1257748A (en) 1989-07-18

Similar Documents

Publication Publication Date Title
DE69027865D1 (de) ZUSAMMENSETZUNGEN enthaltend omega Conotoxin Peptide Derivate und deren Verwendung ZUR BEHANDLUNG VON ISCHÄMIE-ARTIGEN NEURONALEN SCHÄDIGUNGEN
EP0335901A4 (en) Methods and compositions for the treatment of non-ige-mediated diseases
EA200000723A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
FI830958A7 (fi) Koostumuksia terapeuttista tai diagnostista käyttöä varten ja terapeuttinen käsittelymenetelmä.
ATE286510T1 (de) In der behandlung von il4 auslösenden krankheiten nützliche rekombinante il4 antikörper
DE3587741D1 (de) Behandlung von Hautkrankheiten.
DE3777861D1 (de) Behandlung von gasen.
ATE11547T1 (de) Neue d-homosteroide, ihre verwendung und herstellung, sowie pharmazeutische praeparate damit.
FI830959A7 (fi) Koostumuksia terapeuttista tai diagnotista käyttöä varten ja terapeuttinen käsittelymenetelmä.
ATE174798T1 (de) Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation
BG50159A3 (bg) Метод за получаване на производни на пиранобензоксадиазол
ATE30238T1 (de) N-acylderivate von peptiden, ihre herstellung und verwendung bei der bekaempfung von krankheiten und mittel dafuer.
ATE5256T1 (de) Phenylpiperazinderivate von 1,3,4oxadiazolylphenolen, ihre herstellung und diese enthaltende therapeutische mittel.
TR199901385T2 (xx) Piperidin t�revleri.
ATE345809T1 (de) Arzneimittelzusammensetzung enthaltend tcf-ii
DK360884A (da) Farmaceutiske og veterinaere midler til behandling af iskaemiskehjertelidelser
ATE45675T1 (de) Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen.
ATE79615T1 (de) Cardiotonische phenyloxazolone.
ATE30032T1 (de) N-acylderivate von dipeptiden, ihre herstellung und verwendung bei der therapie von krankheiten und mittel dafuer.
FI890810A7 (fi) Palovammojen käsittely
ATE75938T1 (de) Enantiomere des propafenons enthaltende therapeutische mittel.
FI831258A0 (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara benzimidazolderivat
IT8619086A0 (it) Composizioni farmaceutiche comprendenti frammenti di acth per il trattamento terapeutico degli stati di shock e dell'insufficienza respiratoria e cardiocircolatoria.
DE68906028D1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.
TR200000916T2 (tr) İkameli piperidin türevleri.

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee